ADA2 deficiency (DADA2) associated with Evans Syndrome and a severe ADA2 genotype.
暂无分享,去创建一个
P. Sandrin-Garcia | E. Valera | G. R. de Sousa | M. Hershfield | M. Ferriani | L. M. de Carvalho | Ronald R de Moura
[1] R. Geha,et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). , 2020, The Journal of allergy and clinical immunology.
[2] S. Özen,et al. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2 , 2019, The Journal of Rheumatology.
[3] M. Hershfield,et al. Human adenosine deaminase 2 deficiency: A multi‐faceted inborn error of immunity , 2019, Immunological reviews.
[4] C. Ross,et al. Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure , 2018, Journal of Clinical Immunology.
[5] S. Holland,et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. , 2017, Blood.
[6] M. Hershfield,et al. Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency. , 2016, The Journal of pediatrics.
[7] P. Nederkoorn,et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. , 2016, Rheumatology.